title: Portal hypertension and iron depletion in patients with genetic hemochromatosis.
abstract: Clinically, portal hypertension has been considered to be less common and less severe in patients with cirrhosis resulting from iron overload in homozygotes for genetic hemochromatosis than in patients with cirrhosis of other causes. To characterize the prevalence and progression of portal hypertension in genetic hemochromatosis (GH), 120 cirrhosis and iron-overloaded patients were compared with a control group of 120 patients with postnecrotic cirrhosis (PNC) who were matched for gender, age, Child's class, and alcohol abuse. Gastroesophageal endoscopy and abdominal ultrasonography were performed at diagnosis and repeated every 12 months and every 6 months, respectively, to evaluate the presence and severity of varices, the caliber of the portal vein and its collaterals, and splenic size. At diagnosis a similar frequency of varices was observed in patients with GH (25%) and in PNC (24%), as well as of portal vein abnormalities and spleen enlargement. During the follow-up period, all but two of the patients with GH were treated by phlebotomy and depleted of excess iron. After a mean of 6 +/- 4.3 (SD) years of observations (range, 2 to 10 years), varices were improved or completely reversed in 26% of patients with cirrhosis and GH but in only 5% of those with PNC (P < .01). Bleeding from varices was observed in only one patient with GH but in five patients with PNC. Of 22 patients with GH in whom portal hypertension was unmodified or worsened, 16 had coexistent hepatic viral infection.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Istituto di Medicina Interna e Fisiopatologia Medica, Università di Milano, Italy.
authors.forename: A L
authors.initials: AL
authors.lastname: Fracanzani
authors.forename: S
authors.initials: S
authors.lastname: Fargion
authors.forename: R
authors.initials: R
authors.lastname: Romano
authors.forename: D
authors.initials: D
authors.lastname: Conte
authors.forename: A
authors.initials: A
authors.lastname: Piperno
authors.forename: R
authors.initials: R
authors.lastname: D'Alba
authors.forename: C
authors.initials: C
authors.lastname: Mandelli
authors.forename: M
authors.initials: M
authors.lastname: Fraquelli
authors.forename: S
authors.initials: S
authors.lastname: Pacchetti
authors.forename: M
authors.initials: M
authors.lastname: Braga
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006432:Hemochromatosis / Q000150:complications / Q000235:genetics* / Q000473:pathology; D006509:Hepatitis B / Q000150:complications; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D006975:Hypertension, Portal / Q000150:complications* / Q000473:pathology; D007501:Iron / Q000378:metabolism*; D000090463:Iron Deficiencies; D008099:Liver / Q000098:blood supply / Q000473:pathology; D008103:Liver Cirrhosis / Q000150:complications; D008297:Male; D008875:Middle Aged; D011169:Portal Vein / Q000473:pathology; D013154:Spleen / Q000473:pathology
chemical_list: D007501:Iron